News

The gene therapy regimen seems to be working wonders, including restoring nearly all hearing to a seven-year-old patient ...
The biotech will add a pivotal Phase III cohort to its ongoing Phase I/II trial evaluating ATSN-201 in X-linked retinoschisis ...